Literature DB >> 4544318

Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.

R N MacSween, M A Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4544318      PMCID: PMC1553970     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

1.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

2.  Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis.

Authors:  W M Newberry; J W Chandler; T D Chin; C H Kirkpatrick
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

3.  Lymphocyte response to phytohemagglutinin in Hodgkin's disease, lymphatic leukemia and lymphosarcoma.

Authors:  S Trubowitz; B Masek; A Del Rosario
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

4.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  The effect of uremic plasma on lymphocyte transformation.

Authors:  M R Silk
Journal:  Invest Urol       Date:  1967-09

6.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

7.  Development of macrophages in phytohaemagglutinin cultures of blood from patients with idiopathic steatorrhoea and with cirrhosis.

Authors:  G C Winter; C F McCarthy; A E Read; J M Yoffey
Journal:  Br J Exp Pathol       Date:  1967-02

8.  Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis.

Authors:  J J Oppenheim; M Barlow; T A Waldmann; J B Block
Journal:  Br Med J       Date:  1966-08-06

9.  Leukocyte mitosis: suppression in vitro associated with acute infectious hepatitis.

Authors:  B Mella; D J Lang
Journal:  Science       Date:  1967-01-06       Impact factor: 47.728

10.  Serological and histological diagnosis of primary biliary cirrhosis.

Authors:  R B Goudie; R N Macsween; D M Goldberg
Journal:  J Clin Pathol       Date:  1966-11       Impact factor: 3.411

View more
  15 in total

1.  Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.

Authors:  P L Amlot; A Unger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors.

Authors:  B Maisch; P Schuff-Werner; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

3.  The immune response in hepatic cirrhosis: animal and human studies.

Authors:  H C Thomas
Journal:  Proc R Soc Med       Date:  1977-08

Review 4.  Pathogenic mechanisms in primary biliary cirrhosis.

Authors:  H C Thomas; O Epstein
Journal:  Springer Semin Immunopathol       Date:  1980-12

5.  Immunological response in experimentally reactivated toxoplasmosis in mice.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

6.  Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.

Authors:  M Nakao; Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1975

7.  The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity.

Authors:  H C Thomas; C R Singer; N L Tilney; H Folch; R N MacSween
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  Suppressive effect of alcoholic liver disease sera on lymphocyte transformation.

Authors:  G P Young; F J Dudley; M B Van Der Weyden
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

9.  Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance.

Authors:  N Brattig; P A Berg
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.